To see the other types of publications on this topic, follow the link: Therapeutic use.

Journal articles on the topic 'Therapeutic use'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Therapeutic use.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Neekhra, Sachin, Himani Awasthi, and DCP Singh. "Potential Therapeutic use of Streblus asper: A Review." International Journal of Research and Development in Pharmacy & Life Sciences 6, no. 7 (December 2017): 2845–49. http://dx.doi.org/10.21276/ijrdpl.2278-0238.2017.6(7).2845-2849.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Dvorak, J. "Therapeutic use exemption." British Journal of Sports Medicine 40, Supplement 1 (July 1, 2006): i40—i42. http://dx.doi.org/10.1136/bjsm.2006.027490.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Nadler, S. F., M. A. Prybicien, D. Sicher, G. A. Malanga, M. DePrince, and J. E. Bowen. "THERAPEUTIC MODALITY USE." Medicine & Science in Sports & Exercise 33, no. 5 (May 2001): S90. http://dx.doi.org/10.1097/00005768-200105001-00519.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Pradhan, Leena, Nicholas D. Andersen, Christoph Nabzdyk, Frank W. LoGerfo, and Aristidis Veves. "Wound-healing Abnormalities in Diabetes and New Therapeutic Interventions." US Endocrinology 00, no. 01 (2007): 68. http://dx.doi.org/10.17925/use.2007.00.1.68.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Gallagher, Lisa M., and Francois Bethoux. "Therapeutic use of the Arts for Patients with Multiple Sclerosis." US Endocrinology 13, no. 02 (2017): 82. http://dx.doi.org/10.17925/use.2017.13.02.82.

Full text
Abstract:
People with multiple sclerosis (MS) face a wide variety of physical, emotional, and social challenges. A multidisciplinary comprehensive care approach is recommended for the management of MS and its consequences, and non-traditional treatments are increasingly considered by patients and health care providers, particularly for the promotion of wellness in the context of this chronic disease. Previous research has demonstrated the benefits of the therapeutic arts (art therapy, dance and movement therapy, and music therapy) in addressing some of the physiological, psychological, cognitive, social, and spiritual needs of patients facing a variety of chronic illnesses. Our review of the literature suggests that therapeutic art can be beneficial to individuals with MS, particularly in promoting self-efficacy, emotional well-being, and motor control. However, the body of evidence is limited, and further research is needed regarding the outcomes and mechanism of action of therapeutic arts in MS to better understand their role in the management of the consequences of the disease.
APA, Harvard, Vancouver, ISO, and other styles
6

Groeneweg, Stefan, Robin P. Peeters, Theo J. Visser, and W. Edward Visser. "Diagnostic and Therapeutic Challenges in the Allan—Herndon—Dudley Syndrome." US Endocrinology 12, no. 02 (2016): 90. http://dx.doi.org/10.17925/use.2016.12.02.90.

Full text
Abstract:
Thyroid hormone (TH) is important for normal brain development. The TH transporter protein monocarboxylate transporter 8 (MCT8) is crucial to maintain adequate TH levels in the brain during development and throughout life. Mutations in MCT8 result in the Allan–Herndon–Dudley syndrome (AHDS), which is characterized by a severe delay in neurocognitive development, combined with abnormal serum thyroid function tests (TFTs). The combination of an increased (F)T3 and decreased (F)T4 and rT3 serum levels are characteristic for the presence of AHDS in male patients with moderate to severe delay in neurocognitive development. Here, we provide an overview of current insights, challenges and pitfalls in the diagnosis and management of patients with AHDS.
APA, Harvard, Vancouver, ISO, and other styles
7

Tan, Robert S., Chris Ojeih, and Maurita Carrejo. "Potential Therapeutic Role of Androgens in Cognitive Loss Associated with Hypogonadism." US Endocrinology 00, no. 01 (2005): 1. http://dx.doi.org/10.17925/use.2005.00.01.1a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Tan, Robert S., Chris Ojeih, and Maurita Carrejo. "Potential Therapeutic Role of Androgens in Cognitive Loss Associated with Hypogonadism." US Endocrinology 00, no. 01 (2005): 84. http://dx.doi.org/10.17925/use.2005.00.01.84.

Full text
Abstract:
Memory problems late in life are common and are often easy to recognize. Hypogonadism in older men is not as readily identified, but it is also frequently a part of aging. Androgens, such as testosterone, have important hormonal influences on the brain and may prevent and possibly treat cognitive loss, including age-associated memory loss, mild cognitive impairment (MCI), and perhaps even Alzheimer’s disease (AD).There is support from small, prospective clinical trials that suggest the role of testosterone in improving cognitive function in normal men as well as hypogonadal men with AD. This improvement in cognitive function is subtle and is often only measurable on specialized neuropsychological batteries such as those that measure the visual-spatial domain. Patients often report measurable memory improvement in both declarative and procedural domains after receiving testosterone replacement therapy.The rise of gonadotropins, follicle-stimulating hormones (FSHs), and luteinizing hormones (LHs), has been associated with AD.The clinical significance of therapeutic strategies directed to reduce these levels remains to be determined. Current evidence showing that dehydroepiandrosterone (DHEA) improves cognitive function is ambiguous.
APA, Harvard, Vancouver, ISO, and other styles
9

Rodriguez, Mariano, Juan Munoz-Castaneda, and Yolanda Almaden. "Therapeutic Use of Calcitriol." Current Vascular Pharmacology 12, no. 2 (April 2014): 294–99. http://dx.doi.org/10.2174/15701611113119990021.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Wall, Jenny, Sally Davis, and Samantha Ridgway. "Cannabis: its therapeutic use." Nursing Standard 16, no. 10 (November 21, 2001): 39–44. http://dx.doi.org/10.7748/ns2001.11.16.10.39.c3123.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Hogaboam, Cory, Cynthia Bone-Larson, Akihiro Matsukawa, Matthew Steinhauser, Kate Blease, Nicholas Lukacs, and Steven Kunkel. "Therapeutic Use of Chemokines." Current Pharmaceutical Design 6, no. 6 (April 1, 2000): 651–63. http://dx.doi.org/10.2174/1381612003400605.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Whall, Ann L. "THERAPEUTIC USE OF SELF." Journal of Gerontological Nursing 14, no. 2 (February 1, 1988): 38–39. http://dx.doi.org/10.3928/0098-9134-19880201-09.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Jones, Janet. "Therapeutic use of metaphor." Nursing Standard 6, no. 11 (December 4, 1991): 30–32. http://dx.doi.org/10.7748/ns.6.11.30.s34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Hebert, Steven C. "Therapeutic Use of Calcimimetics." Annual Review of Medicine 57, no. 1 (February 2006): 349–64. http://dx.doi.org/10.1146/annurev.med.57.121304.131328.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

&NA;, &NA;. "Therapeutic Use for Nicotine?" AJN, American Journal of Nursing 94, no. 6 (June 1994): 50. http://dx.doi.org/10.1097/00000446-199406000-00025.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Pridmore, Saxby. "Therapeutic use of rTMS." Nature Reviews Neuroscience 8, no. 10 (October 2007): 808. http://dx.doi.org/10.1038/nrn2169-c1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Ridding, Michael C., and John C. Rothwell. "Therapeutic use of rTMS." Nature Reviews Neuroscience 8, no. 10 (October 2007): 808. http://dx.doi.org/10.1038/nrn2169-c2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

DE Gaudio, A. R. "Therapeutic Use of Albumin." International Journal of Artificial Organs 18, no. 4 (April 1995): 216–24. http://dx.doi.org/10.1177/039139889501800407.

Full text
Abstract:
The clinical use of albumin solutions is a controversial issue, that involves albumin as a volume plasma expander, a supplement of total parenteral nutrition and a substance with pharmacological properties. The aim of this review is to show the present role of albumin in the clinical setting. We reviewed experimental and clinical data collected by the Medline System and the bibliographies of relevant articles. Experimental studies were selected on the basis of their historical value and applicability (hypothetical use, correct use) to the clinical setting. At present, it is possible to assert that: a) exogenous albumin is not an ideal colloid; b) the effects on plasma volume expansion are not entirely predictable, especially in pathologic states accompanied by leaky capillary membranes; c) albumin supplementation shows no benefit on many kinds of tissue edema; d) the supplementation of albumin has no influence on outcome. It is possible to demonstrate the role of albumin as a substance with unique properties that make it useful, but further experimental and clinical data will be necessary and represent new areas for future exploration. Given the protein's cost, the routine use of albumin does not appear to be justified, until new data indicate otherwise.
APA, Harvard, Vancouver, ISO, and other styles
19

Soothill, James, Catherine Hawkins, Erik Änggår, and David Harper. "Therapeutic use of bacteriophages." Lancet Infectious Diseases 4, no. 9 (September 2004): 544–45. http://dx.doi.org/10.1016/s1473-3099(04)01127-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Grotenhermen, Franjo. "Therapeutic use of cannabis." Lancet 351, no. 9104 (March 1998): 758–59. http://dx.doi.org/10.1016/s0140-6736(05)78538-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Winblad, Bengt, Mario Fioravanti, Tomas Dolezal, Inara Logina, Ivan Gospodinov Milanov, Dinu Cristian Popescu, and Alina Solomon. "Therapeutic Use of Nicergoline." Clinical Drug Investigation 28, no. 9 (2008): 533–52. http://dx.doi.org/10.2165/00044011-200828090-00001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Stiehm, E. Richard, Jordan S. Orange, Mark Ballow, and Heather Lehman. "Therapeutic Use of Immunoglobulins." Advances in Pediatrics 57, no. 1 (January 2010): 185–218. http://dx.doi.org/10.1016/j.yapd.2010.08.005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Grotenhermen, Franjo. "Cannabinoids for Therapeutic Use." American Journal of Drug Delivery 2, no. 4 (2004): 229–40. http://dx.doi.org/10.2165/00137696-200402040-00003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Shore, Lisa B. "Therapeutic Use of Touch." Pediatric Physical Therapy 9, no. 1 (1997): 41. http://dx.doi.org/10.1097/00001577-199700910-00016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Goelitz, Ann, and Abigail Stewart Kahn. "Therapeutic Use of Space." Journal of Creativity in Mental Health 2, no. 4 (March 4, 2008): 31–44. http://dx.doi.org/10.1300/j456v02n04_04.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Balazs, Endre A. "Therapeutic use of hyaluronan." Structural Chemistry 20, no. 2 (March 4, 2009): 341–49. http://dx.doi.org/10.1007/s11224-009-9435-y.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Kamra, Pooja, Mahaveer Singh, Hardarshan Singh Lamba, and Birendra Srivastava. "Scientific Basis for the Therapeutic use of Plectranthus ambonicus: A Review." International Journal of Pharma Research and Health Sciences 7, no. 6 (December 2019): 3072–80. http://dx.doi.org/10.21276/ijprhs.2019.06.01.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Singh, Kalpana, and Arvind Kumar Srivastava. "THERAPEUTIC USES OF BUTEA MONOSPERMA." Era's Journal of Medical Research 9, no. 2 (December 2022): 218–23. http://dx.doi.org/10.24041/ejmr2022.34.

Full text
Abstract:
New synthetic drugs have many side effects on health as compared to the traditional herbs used in the past.The use of medicinal plants have been en established source for a relief from illness which can be traced back over five millennia. Antibiotics are one of the life saving weapons for humans but over the past few decades these health benefits are under threat as antibiotics have become less effective and also create toxic after effects affecting human life more. The well-known medicinal herb Butea monosperma is a moderately Sizeable deciduous tree and is widely dispersed in Asian hemispheres, Burma and Sri Lanka. From time to time it has been used in traditional medicinal practices. It has been mentioned in ayurveda for medicinal uses and mythological references, also The population's health care system continues to be heavily influenced by traditional medical practises, homoeopathy, and folklore. Rural and tribal people utilise the herb extensively to treat a variety of ailments. It is known in many languages apart from its botanical name. It is called Flame of forest, Dhak, Palash etc. It has been used to treat a variety of illnesses including cancer, diabetes, dysentery, fever, jaundice, diarrhoea, and jaundice, among others. A great variety of phytochemicals, primarily flavonoids, lactones, diterpenoids, phytosterols, etc., are present in the plant's aerial portion. The need for new antimicrobial compounds from alternative sources has arisen as a result of the development of drug resistance in human infections against routinely used antibiotics. Finding possible novel chemicals for therapeutic purposes requires screening medicinal plants for antibacterial and phytochemical properties .
APA, Harvard, Vancouver, ISO, and other styles
29

Salvi, Mario, Guia Vannucchi, and Paolo Beck-Peccoz. "Rituximab for the Treatment of Graves’ Orbitopathy." US Endocrinology 07, no. 02 (2011): 130. http://dx.doi.org/10.17925/use.2011.07.02.130.

Full text
Abstract:
The contribution of B-cells to human autoimmune disease has recently been underscored because of the therapeutic benefit of B-cell depleting therapies. B-cells are involved in the production of autoantibodies, and in CD4+ T-cell activation, control of T-cell function, and inflammation through cytokine production. B-cells are also important antigen-presenting cells. Rituximab (RTX) has been used off-label in various autoimmune disorders and has been shown to effectively deplete mature and memory CD20+ B-cells, but not long-lived plasma cells. The rationale behind the use of RTX in Graves’ disease (GD) and Graves’ orbitopathy (GO) relies on its putative effect on pathogenic autoantibodies causing hyperthyroidism. RTX in patients with active GO has been shown to have a significant effect on the inflammatory activity and severity of GO. However, caution is suggested before proposing RTX as a novel therapeutic tool in this disease until randomized controlled trials are available. Should preliminary observations be confirmed, an optimal strategy for controlling the progression of GO would be to pursue B-cell depletion shortly after diagnosis, rather than only as an alternative therapeutic option when standard immunosuppression has failed.
APA, Harvard, Vancouver, ISO, and other styles
30

Alam, Md Khorshed, Md Obydul Hoq, and Md Shahab Uddin. "Therapeutic use of Withania somnifera." Asian Journal of Medical and Biological Research 2, no. 2 (August 9, 2016): 148–55. http://dx.doi.org/10.3329/ajmbr.v2i2.29004.

Full text
Abstract:
Withania somnifera (L) Dunal is commonly called as Ashwagandha/Asgand and it belongs to the family Solanaceae. It is a well known medicinal plant widely used in the treatment of many clinical conditions in Indian subcontinent. It is an important medicinal plant commonly known as Asgand which has been used either single or in combination with other drugs in Unani as well as Ayurvedic system of medicine for centuries. It has been described by Dioscorides (78 AD) in his book “Kitab-ul-Hashaish”. Asgand consists of the roots of Withania somnifera which has various therapeutic actions such as anti - inflammatory (Muhallil-e-Warm), sedative (Musakkin), aphrodisiac (Muqawwi-e-Bah), hepatoprotective, immune-modulator activity, anti-oxidant, anti-ageing, anti-tumour activity, adaptogenic activity and has anti-anticonvulsant activity. Keeping in view the medicinal properties of Withania somnifera Dunal (Asgand), an attempt has been made in this paper to explore various dimensions of the drug including phytochemical and pharmacological studies carried out on this herb.Asian J. Med. Biol. Res. June 2016, 2(2): 148-155
APA, Harvard, Vancouver, ISO, and other styles
31

Hossain, Md Tofazzal, and Md Obydul Hoq. "Therapeutic use of Adhatoda vasica." Asian Journal of Medical and Biological Research 2, no. 2 (August 9, 2016): 156–63. http://dx.doi.org/10.3329/ajmbr.v2i2.29005.

Full text
Abstract:
Adhatoda vasica Nees belonging to family Acanthaceae, commonly known as Adosa, is found many regions of India and throughout the world, with a multitude of uses in traditional Unani and Ayurvedic systems of medicine. It is also called “Vasaka”. It is a well-known herb in indigenous systems of medicine for its beneficial effects, particularly in bronchitis. Vasaka leaves, bark, the root bark, the fruit and flowers are useful in the removal of intestinal parasites. Vasaka herb is used for treating cold, cough, chronic bronchitis and asthma. In acute stages of bronchitis, vasaka gives unfailing relief, especially where the sputum is thick and sticky. It liquefies the sputum so that it is brought up more easily. For relief in asthma, the dried leaves should be smoked. The juice from its leaves should be given in doses of 2 to 4 grams in treating diarrhea and dysentery. A poultice of its leaves can be applied with beneficial results over fresh wounds, rheumatic joints and inflammatory swellings. A warm decoction of its leaves is useful in treating scabies and other skin diseases. In olden times its leaves were made into a decoction with pepper and dried ginger. But the modern medicine searched its active ingredients and found out that vasicine, oxyvascicine and vasicinone are the alkaloids present in vasaka and in which vasicine is the active ingradient for expelling sputum from the body.Asian J. Med. Biol. Res. June 2016, 2(2): 156-163
APA, Harvard, Vancouver, ISO, and other styles
32

Nasser, Abdullah. "Ready-to-use therapeutic foods." University of Western Ontario Medical Journal 83, no. 2 (December 23, 2014): 26–27. http://dx.doi.org/10.5206/uwomj.v83i2.4440.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Medeiros, Aldo Cunha, and Vanessa De Fátima Lima de Paiva Medeiros. "Therapeutic use of coconut water." JOURNAL OF SURGICAL AND CLINICAL RESEARCH 3, no. 2 (June 3, 2013): 83. http://dx.doi.org/10.20398/jscr.v3i2.3570.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Poulton, James L., and Donald S. Strassberg. "The Therapeutic Use of Reminiscence." International Journal of Group Psychotherapy 36, no. 3 (July 1986): 381–98. http://dx.doi.org/10.1080/00207284.1986.11490910.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Bell, Susan Givens. "The Therapeutic Use of Honey." Neonatal Network 26, no. 4 (July 2007): 247–51. http://dx.doi.org/10.1891/0730-0832.26.4.247.

Full text
Abstract:
THE ANCIENTS WROTE OF THE healing properties of honey. A Sumerian tablet, possibly dated 3000 BCE, documents the treatment of an infected skin ulcer with honey. An Egyptian papyrus dated around 2000 BCE notes the use of honey to treat a gaping wound penetrating to the bone near the eyebrow. Aristotle (384–322 BCE) wrote about the use of honey to treat wounds and sore eyes. As with those of other natural substances, the healing benefits of honey were passed from generation to generation. Honey continues to be a popular medicine throughout the world, except in the U.S.1
APA, Harvard, Vancouver, ISO, and other styles
36

Salladay, Susan A. "Should Christians Use Therapeutic Touch?" Christian bioethics: Non-Ecumenical Studies in Medical Morality 8, no. 1 (April 1, 2002): 25–42. http://dx.doi.org/10.1093/chbi.8.1.25.8756.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Ehrenfeld, M., and R. Bergman. "The Therapeutic Use of Dolls." Perspectives in Psychiatric Care 31, no. 4 (January 16, 2009): 21–22. http://dx.doi.org/10.1111/j.1744-6163.1995.tb00484.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Bechler-Karsch, Abby. "The Therapeutic Use of Music." Worldviews on Evidence-Based Nursing E1, no. 1 (December 1994): 23–33. http://dx.doi.org/10.1111/j.1524-475x.1993.00023.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Brock, Medina. "The Therapeutic Use of Clay." British Journal of Occupational Therapy 54, no. 1 (January 1991): 13–15. http://dx.doi.org/10.1177/030802269105400108.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Krenning, Eric P., and Marion de Jong. "Therapeutic use of radiolabelled peptides." Annals of Oncology 11 (2000): 267–72. http://dx.doi.org/10.1093/annonc/11.suppl_3.267.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Rode, Diane, Kathleen Leask Capitulo, Merri Fishman, and Gary Holden. "The Therapeutic Use of Technology." American Journal of Nursing 98, no. 12 (December 1998): 32–35. http://dx.doi.org/10.1097/00000446-199812000-00037.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Rode, Diane, Kathleen Leask Capitulo, Merri Fishman, and Gary Holden. "The Therapeutic Use of Technology." AJN, American Journal of Nursing 98, no. 12 (December 1998): 32–35. http://dx.doi.org/10.1097/00000446-199898120-00021.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Andrews, A. "Therapeutic use of bovine somatotrophin." Veterinary Record 132, no. 21 (May 22, 1993): 540. http://dx.doi.org/10.1136/vr.132.21.540-a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Salladay, S. A. "Should Christians Use Therapeutic Touch?" Christian Bioethics 8, no. 1 (January 1, 2002): 25–42. http://dx.doi.org/10.1076/chbi.8.1.25.8756.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Little, John. "The therapeutic use of ‘no’." Australasian Psychiatry 23, no. 2 (February 12, 2015): 136–38. http://dx.doi.org/10.1177/1039856214568225.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Cohen, Susan M., Mary Ellen Rousseau, and Elizabeth H. Robinson. "Therapeutic Use of Selected Herbs." Holistic Nursing Practice 14, no. 3 (April 2000): 59–68. http://dx.doi.org/10.1097/00004650-200004000-00010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Cazenave, S. O. S., C. L. Correa, E. C. Freitas, and L. Matias. "Unsanctioned use of therapeutic drugs." Toxicology Letters 95 (July 1998): 122. http://dx.doi.org/10.1016/s0378-4274(98)80483-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Oliviero, A. "C35 Therapeutic use of TMS." Clinical Neurophysiology 119 (May 2008): S70. http://dx.doi.org/10.1016/s1388-2457(08)60267-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Anderegg-Wirth, Elisabeth. "Tranquilizers: Therapeutic use and pharmacology." Pharmaceutica Acta Helvetiae 72, no. 2 (April 1997): 123. http://dx.doi.org/10.1016/s0031-6865(97)00009-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Stiehm, E. Richard. "Appropriate therapeutic use of immunoglobulin." Transfusion Medicine Reviews 10, no. 3 (July 1996): 203–21. http://dx.doi.org/10.1016/s0887-7963(96)80060-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography